GPS Wealth Strategies Group’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-1
Closed -$99 – 674
2025
Q3
$99 Hold
1
– – ﹤0.01% 1625
2025
Q2
$106 Buy
+1
New +$101 ﹤0.01% 1584
2023
Q2
– Sell
-2
Closed -$249 – 1249
2023
Q1
$249 Buy
+2
New +$275 ﹤0.01% 1218
2022
Q4
– Sell
-47
Closed -$6K – 231
2022
Q3
$6K Hold
47
– – ﹤0.01% 855
2022
Q2
$7K Buy
47
+20
+74% +$3.06K ﹤0.01% 821
2022
Q1
$5K Hold
27
– – ﹤0.01% 834
2021
Q4
$7K Buy
27
+2
+8% +$548 ﹤0.01% 795
2021
Q3
$7K Sell
25
-25
-50% -$7.95K ﹤0.01% 774
2021
Q2
$11K Sell
50
-150
-75% -$28.3K ﹤0.01% 706
2021
Q1
$21K Buy
+200
New +$21.2K 0.01% 529

Other funds holding BNTX

GPS Wealth Strategies Group's BNTX Position: Q4 2025 in Review

GPS Wealth Strategies Group sold out of BioNTech (BNTX) in Q4 2025, closing a stake of 1 share — an estimated $99 sold.

GPS Wealth Strategies Group first reported a position in BNTX in Q1 2021 and held it in 10 quarters. The position peaked at $21K in Q1 2021. 284 funds tracked by Wall St. Rank hold BNTX as of Q4 2025.

  • GPS Wealth Strategies Group reported no remaining BioNTech position as of Q4 2025 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 1 BioNTech share in Q4 2025, an estimated $99.
  • GPS Wealth Strategies Group first reported a position in BioNTech in Q1 2021 and held it in 10 quarters.
  • GPS Wealth Strategies Group's BioNTech position peaked at $21K in Q1 2021.
  • 284 funds tracked by Wall St. Rank held BioNTech as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.